Skip to main content
. 2018 Feb 8;13(Suppl 1):10. doi: 10.1186/s13023-017-0749-3

Table 2.

Comparison between the PHARE-M Group and the paired Control Group

Comparison between PHARE-M Group and Control Group PIIARE-M (N = l104) Controles
(N = 1104)
Patients PHARE non paired
(N = 205)
Comparison between PIIARE-M Group and Control Group (proc TTEST)
Gender Men n (%) 582 (52.72) 564 (51.09) 93 (45.37)
Female n (%) 522 (47.28) 540 (48.91) 112 (54.63)
Age Average 15.57 16.05 14.48
Std Deviation 10.73 11.00 10.51
Age (classes) 0-04 n (%) 182 (16.49) 175 (15.85) 32 (15.611)
05-09 n (%) 209 (18.93) 206 (18.66) 42 (20.49)
10-14 n (%) 213 (19.29) 204 (18.48) 48 (23.41)
15-19 n (%) 169 (15.31) 168 (15.22) 38 (18.54)
20-24 n (%) 125 (11.32) 130 (11.78) 19 (927)
25-29 n (%) 93 (8.42) 84 (7.61) 10 (4.88)
30-34 n (%) 53 (4.80) 68 (6.16) 4 (1.95)
35-39 n (%) 36 (3.26) 34 (3.08) 6 (2.93)
40-44 n (%) 7 (0.63) 18 (1.63) 1 (0.49)
45-49 n (%) 9 (0.82) 11 (1.00) 4 (1.95)
50-54 n (%) 4 (0.36) 3 (0.27) 0
55-59 n (%) 4 (0.36) 2 (0.18) 0
60-64 n (%) 0 0 1 (0.49)
70-74 n (%) 0 1 (0.09) 0
VEMS Nmtss 223 270 49 (p = 0.0012 IS)
Average 83.00 79.11 85 06
Std Deviation 23.96 25.81 21.92
ZBMI Nmiss 7 39 2 p = 0.5171 (NS>)
Average -0.17 -0.14 -0.18
Std Deviation 1.05 1.15 1.11

S Significant; NS Non Significant